Cover Image
市場調查報告書

Torii:產品平台分析

Torii Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 293990
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
Torii:產品平台分析 Torii Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
出版日期: 2014年06月15日 內容資訊: 英文 26 Pages
簡介

本報告提供Torii的治療藥開發平台現狀及各開發階段的比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,彙整最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

Torii的基本資料

Torii概要

  • 主要資訊
  • 企業資料

Torii:R&D概要

  • 主要的治療範圍

Torii:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Torii:開發中產品概況

  • 最後階段的開發中產品
    • 登記前的產品/聯合治療模式
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 藥物研發中的產品/聯合治療模式

Torii:藥物簡介

  • MK-8237
  • TO-206
  • 杉花粉過敏用疫苗

Torii:開發平台分析

  • 各給藥途徑
  • 各分子類型

Torii:最近的開發平台趨勢

Torii:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC05015CDB

Global Markets Direct's, 'Torii Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Torii Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Torii Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Torii Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Torii Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Torii Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Torii Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Torii Pharmaceutical Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Torii Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Torii Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Torii Pharmaceutical Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Torii Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Torii Pharmaceutical Co., Ltd. Snapshot
    • Torii Pharmaceutical Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Torii Pharmaceutical Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Torii Pharmaceutical Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Torii Pharmaceutical Co., Ltd. - Pipeline Products Glance
    • Torii Pharmaceutical Co., Ltd. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Torii Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Torii Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Torii Pharmaceutical Co., Ltd. - Drug Profiles
    • allergenic pollen extract of timothy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MK-8237
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TO-206
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Cedar Pollen Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Torii Pharmaceutical Co., Ltd. - Pipeline Analysis
    • Torii Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
    • Torii Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
  • Torii Pharmaceutical Co., Ltd. - Recent Pipeline Updates
  • Torii Pharmaceutical Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Torii Pharmaceutical Co., Ltd., Key Information
  • Torii Pharmaceutical Co., Ltd., Key Facts
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Torii Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Torii Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
  • Torii Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014
  • Torii Pharmaceutical Co., Ltd. - Pre-Registration, 2014
  • Torii Pharmaceutical Co., Ltd. - Phase III, 2014
  • Torii Pharmaceutical Co., Ltd. - Phase I, 2014
  • Torii Pharmaceutical Co., Ltd. - Discovery, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014
  • Torii Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014
  • Torii Pharmaceutical Co., Ltd., Other Locations

List of Figures

  • Torii Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Torii Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Torii Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
Back to Top